Efficacy and Safety of Glecaprevir/Pibrentasvir in Combination Therapy in Chronic Hemodialysis Patients with Genotype 2 Hepatitis C Virus Infection

ISSN Print: 2163-9450
ISSN Online: 2163-9469
www.scirp.net/journal/ojgas/
E-mail: [email protected]

Citations

"Efficacy and Safety of Glecaprevir/Pibrentasvir in Combination Therapy in Chronic Hemodialysis Patients with Genotype 2 Hepatitis C Virus Infection"
written by Naoki Hotta,
published by Open Journal of Gastroenterology, Vol.9 No.1, 2019

has been cited by the following article(s):

[1]	Возможности современных пангенотипных противовирусных препаратов для лечения хронического гепатита C у больных, получающих лечение …
	Нефрология и …, 2021

[2]	Glecaprevir and Pibrentasvir Combination Antiviral Therapy for Hemodialysis Patients Infected with the Hepatitis C Virus
	Advanced Research in …, 2020

[3]	A preliminary PET radiomics study of brain metastases using a fully automatic segmentation method
	2020

[4]	Effectiveness and safety of glecaprevir and pibrentasvir for hemodialysis patients with hepatitis C virus infection at a single center
	2019